Overview
The [Cys26]-beta-Amyloid (1-42) peptide is a significant asset for research in Alzheimer’s disease and related neurological disorders. This unique variant, where Ser 26 is substituted with Cys, facilitates the generation of covalently linked Aβ1-42 homodimers. Understanding its aggregation properties can shed light on the mechanisms underlying amyloid plaque formation, a hallmark of Alzheimer’s pathology.
Key Features
- Covalently linked Aβ1-42 homodimer generation
- Allows for detailed aggregation studies
- Reversible dimerization upon the addition of reducing agents
- Useful model for exploring amyloid aggregation
- High purity suitable for research applications
Specifications
| Product Name | Weight | Purity |
|---|---|---|
| [Cys26]-beta-Amyloid (1-42) | 1 mg | ≥95% |
FAQ
What applications can I use [Cys26]-beta-Amyloid (1-42) for?
This peptide is particularly useful for aggregation studies related to Alzheimer’s disease, providing a model to investigate the formation of amyloid plaques.
Can the dimerization be reversed?
Yes, the dimerization of this peptide can be reverted by adding a reducing agent, allowing researchers to explore its properties in both dimerized and monomeric states.
Where can I find more related peptides?
You can explore our extensive collection of peptides for various research needs, including innovative tools and substrates.
For your next research project, consider the [Cys26]-beta-Amyloid (1-42) to deepen your understanding of peptide interactions and amyloid pathologies. Our commitment to high-quality peptides ensures that you receive reliable products that meet your research requirements.



![[Cys26]-beta-Amyloid (1-42)](https://anaspecstore.com/wp-content/uploads/2026/10/as-63672-05-img-en-as-63672-05-01.jpg)
Reviews
There are no reviews yet.